David S.P. Tan

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Nicoletta Colombo, Cristiana Sessa, Andreas du Bois et al. · Annals of Oncology · 2019 · 1.1K citations · Full text

Borderline Tumours, Tumoral Pathology, Medicine +9

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With <i>BRCA1</i> and <i>BRCA2</i> Mutations

David S.P. Tan, Christian Rothermundt, Karen Thomas et al. · Journal of Clinical Oncology · 2008 · 470 citations

Breast cancer molecular profiling with single sample predictors: a retrospective analysis

Britta Weigelt, Alan Mackay, Roger A’Hern et al. · The Lancet Oncology · 2010 · 359 citations · Full text

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

David S.P. Tan, Caterina Marchiò, Robin L. Jones et al. · Breast Cancer Research and Treatment · 2007 · 317 citations

Breast Oncology, Prognostic Impact, Medicine +9

Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Philipp Harter, Alexandra Léary, Domenica Lorusso et al. · Annals of Oncology · 2023 · 316 citations · Full text

Gynecological Surgery, Epithelial Ovarian Cancer, Cancer Recurrence +7